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SUMMARY. The paper presents a study on antioxidants’ effects on the stability of perfusion and organ
preservation liquids, in order to obtain medicinal products characterized by higher stability and efficien-
cy. The subject of this study was a genuine ViaSpan liquid, the composition of which was modified by re-
placing glutathione with selected antioxidants, e.g. vitamin C, cysteine, and fumaric acid in concentrations
of 0.1, 0.3, and 0.5 mmol/l. Liquid stability was evaluated using an “accelerated stability” test. Results in-
dicate that the suggested antioxidants have a significant effect on extending the stability of the ViaSpan
liquid. The best results are achieved when the genuine liquid is supplemented with ascorbic acid at a con-
centration of 0.45 mmol/l. An extension in the ViaSpan liquid’s stability from 117 to 178 days was
achieved; corresponding to a 1.5-fold increase. 
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